Zeiss and Envision Health partner on VR-based glaucoma testing
Go back to Zeiss and Envision Health partner on VR-based glaucoma testing| Carl Zeiss Meditec AG Unsponsored ADR (AMEX: CZMWY) | Delayed: 37.81 +0.49 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.32 | 52 Week High | $41.68 | |||
| Open | $37.78 | 52 Week Low | $28.06 | |||
| Day High | $38.12 | P/E | N/A | |||
| Day Low | $37.78 | EPS | $0.00 | |||
| Volume | 958 | |||||
